Lexaria Bioscience Corp. (CSE: LXX) (OTCQX: LXRP) Grows IP Portfolio with Three More Patents in Australia, Two Notices of Allowance in the US
LXRP receives three new Australian patents and two new notices of allowance from the U.S. patent office; the company expects to receive corresponding patents by year-end 2018 If issued in both Australia and the U.S., LXRP would then hold 12 issued patents within its first patent family, and it continues to pursue pending application claims in this patent family globally The company, which has filed more than 50 patent applications globally, out-licenses its technology that promotes healthier and faster ingestion methods and lower overall dosing Lexaria Bioscience Corp. (CSE: LXX) (OTCQX: LXRP), which owns the patented DehydraTECH (trademarked) ingestion technology…